Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A New Cell-Cycle Target in Cancer - Inhibiting Cyclin D-Dependent Kinases 4 and 6.

× No keyword cloud information.

17 in total

Review 1. Cellular senescence in gastrointestinal diseases: from pathogenesis to therapeutics.

Authors: Nina Frey; Sascha Venturelli; Lars Zender; Michael Bitzer
Journal: Nat Rev Gastroenterol Hepatol Date: 2017-11-29 Impact factor: 46.802

Review 2. Recent advances of cyclin-dependent kinases as potential therapeutic targets in HR+/HER2- metastatic breast cancer: a focus on ribociclib.

Authors: Dumessa Edessa; Mekonnen Sisay
Journal: Breast Cancer (Dove Med Press) Date: 2017-12-06

3. CNS penetration of the CDK4/6 inhibitor ribociclib in non-tumor bearing mice and mice bearing pediatric brain tumors.

Authors: Yogesh T Patel; Abigail Davis; Suzanne J Baker; Olivia Campagne; Clinton F Stewart
Journal: Cancer Chemother Pharmacol Date: 2019-05-11 Impact factor: 3.333

Review 4. Targeting CDK4 and CDK6 in cancer.

Authors: Shom Goel; Johann S Bergholz; Jean J Zhao
Journal: Nat Rev Cancer Date: 2022-03-18 Impact factor: 69.800

Review 5. Developmental Therapeutics in Myeloproliferative Neoplasms.

Authors: Prithviraj Bose; Srdan Verstovsek
Journal: Clin Lymphoma Myeloma Leuk Date: 2017-07

6. Investigation of the Anticancer Mechanism of Isoorientin Isolated from Eremurus Spectabilis Leaves via Cell Cycle Pathways in HT-29 Human Colorectal Adenocarcinoma Cells.

Authors: Gulsah Gundogdu; Yavuz Dodurga; Levent Elmas; Seymanur Yilmaz Tasci; Esen Sezen Karaoglan
Journal: Eurasian J Med Date: 2018-10

7. Palbociclib Renders Human Papilloma Virus-Negative Head and Neck Squamous Cell Carcinoma Vulnerable to the Senolytic Agent Navitoclax.

Authors: Nicholas J Gadsden; Cory D Fulcher; Daniel Li; Nitisha Shrivastava; Carlos Thomas; Jeffrey E Segall; Michael B Prystowsky; Nicolas F Schlecht; Evripidis Gavathiotis; Thomas J Ow
Journal: Mol Cancer Res Date: 2021-01-25 Impact factor: 5.852

8. Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptome.

Authors: Michael Rusch; Joy Nakitandwe; Sheila Shurtleff; Scott Newman; Zhaojie Zhang; Michael N Edmonson; Matthew Parker; Yuannian Jiao; Xiaotu Ma; Yanling Liu; Jiali Gu; Michael F Walsh; Jared Becksfort; Andrew Thrasher; Yongjin Li; James McMurry; Erin Hedlund; Aman Patel; John Easton; Donald Yergeau; Bhavin Vadodaria; Ruth G Tatevossian; Susana Raimondi; Dale Hedges; Xiang Chen; Kohei Hagiwara; Rose McGee; Giles W Robinson; Jeffery M Klco; Tanja A Gruber; David W Ellison; James R Downing; Jinghui Zhang
Journal: Nat Commun Date: 2018-09-27 Impact factor: 14.919

9. Tenascin-C Modulates Cell Cycle Progression to Enhance Tumour Cell Proliferation through AKT/FOXO1 Signalling in Pancreatic Cancer.

Authors: Jun Cai; Wenli Lu; Shaoxia Du; Zhongkui Guo; Hui Wang; Wei Wei; Xiaohong Shen
Journal: J Cancer Date: 2018-10-31 Impact factor: 4.207

Review 10. Potential Mechanisms Connecting Purine Metabolism and Cancer Therapy.

Authors: Jie Yin; Wenkai Ren; Xingguo Huang; Jinping Deng; Tiejun Li; Yulong Yin
Journal: Front Immunol Date: 2018-07-30 Impact factor: 7.561